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INTRODUCTION
Coronavirus disease 2019 (COVID-19) is an infectious disease caused
by severe acute respiratory syndrome, coronavirus 2 (SARS-KOV-2).
As is well known, COVID-19 has become a global pandemic and a
serious health problem.
The disease was first reported in December 2019 in Wuhan, China,
which spread rapidly and caused a global pandemic.
PANDEMIC COVID-19
Computed tomography (CT) is strongly recommended in
suspicious cases of COVID-19 or at initial assessment and
monitoring.
Known radiological features of COVID-19 pneumonia on CT
are: bilateral extensive obstruction of milk glass with peripheral
distribution, mainly involving the lower lobes.
Uncommon parenchymal and/or extraparenchymal
complications may occur: pleural and pericardial effusion,
lymphadenopathy, cavitation, halo-sign on CT, and
pneumothorax.
INTRODUCTION
Retrospective studies in patients with COVID-19 suggest that pneumothorax
may occur in 1% of patients seeking hospitalization, 2% of patients seeking
intensive care unit (ICU), and 1% of patients dying from infection.
The incidence of pneumothorax and pneumomediastinum in patients with
mechanical ventilation is 15%.
Spontaneus pneumothorax has been reported as a complication of severe
acute respiratory syndrome with an incidence of 1.7% in hospitalized
patients.
Pneumothorax has been reported as a poor prognostic factor in patients with
coronavirus infection with severe respiratory syndrome.
Our case aims to describe the clinical features of a patient with these
diagnoses and to encourage consideration of the association of COVID-19
and pneumothorax as a possible poor prognostic factor.
CASE REPORT
PANDEMIC  (COVID-19)
 46-year-old man, without other comorbidities, admitted to the infectious ward 
due to 7-day temperature up to 38°C, fatigue, malaise, dry cough, shortness of 
breath
 Treated by a family doctor, but without improvement. 
 On admission, vital signs: T=37.8°C, pulse 60/min, SpO2=87%
 Laboratory tests, chest CT, CT pulmoangiography and molecular 
nasopharyngeal swab test for SARS-CoV-2 were performed (twice positive)
 The patient was treated with infusions, antibiotics, analgesics and vitamin 
therapy
Dry Cough Fever Shortness Of Breath Fatigue
Case in a non-intubated patient with pneumothorax and COVID-19, (without previous history of lung disease or requiring 
positive pressure ventilation). 
Physical examination
Conscious, contactable, febrile, 
eupnoic, eucardic, wet and white 
coated tounge
Enhanced fremitus pectoralis
Percutaneus dullness right in middle 




Inaudible breathing in basal and 
middle parties right, and left basal 
crepitation and finding of dry scraping 
noises in the middle parties
AUSCULTATION
CT findings
27.08.2020 (CT pulmoangiography) 14.08.2020 (native CT)
Figure 1. Diffuse multiple zones of bilateral 
interstitial pneumonia, milk glass atenuation, free 
mediastinum and pleural spaces.
Figure 2-7. In the right lung, massive pneumothorax with collapsed lung with hyperdense zones of 








27.08.2020 – Skopje, Thoracic surgery
(surgical ward for further treatment)27.08.2020 (CT pulmoangiography)
In the left lung diffuse reticulotracotic fibrous changes as well 
as subpleural focal fibrosis which are basally posterior in the 







There are several studies where spontaneous pneumothorax is a
common complication of severe acute respiratory syndrome.
A retrospective study, From March to June 2020, included 71
patients from 16 centers, of whom 60 had pneumothorax (6 of
whom also had pneumomediastinum), while 11 patients had
pneumomediastinum alone.
The clinical study included patients who already had pneumothorax
on the day of admission, patients who developed pneumothorax or
pneumomediastinum during their hospital admission, COVID-19
patients who developed their complication with intubation and
ventilation.
Survival for 28 days was not significantly different between
patients with pneumothorax (63.1% ± 6.5%) or with isolated
pneumomediastinum (53.0% ± 18.7%; p = 0.854).
The incidence of pneumothorax was higher in men.
28-day survival was not different between the sexes (men 62.5% ±
7.7% versus women 68.4% ± 10.7%; p = 0.619).
Patients over 70 years of age had significantly lower 28-day
survival than younger subjects (≥70 years 41.7% ± 13.5% survival
versus <70 years 70.9% ± 6.8% survival; p = 0.018 log rank).
Anthony W. Martinelli et al. Eur Respir J 
doi:10.1183/13993003.02697-2020
Mortality following pneumothorax or 
pneumomediastinum in COVID-19. 
Relationship between sex, 
age, ventilatory support 




be aware that 
pneumothorax 








Pneumothorax is rarely 
associated with COVID-
19 pneumonia. COVID19 
spontaneous 
pneumothorax 
associated with an 
otherwise healthy 
individual may be an 
undiagnosed entity. This 
association may be 
secondary to 













By presenting this 
case we emphasize 
the possible clinical 
scenario of 
spontaneous 
pneumothorax 
accompanied by 
COVID-19 
pneumonia through 
CT finding.
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THANK YOU
PLEASE, TAKE CARE
